Objective : In the so-called primary intracerebral hemorrhage (ICH), lobar and deep ICH were mainly due to cerebral amyloid angiopathy and deep perforating arterial disease. Our aim was to identify specifics of warfarin associated ICH (WAICH) and to focus on differences in susceptibility to warfarin according to the underlying vasculopathies, expressed by ICH location.
INTRODUCTION
The high prevalence of atrial fibrillation in the aging population has led to an increasing incidence of warfarin associated intracerebral hemorrhage (WAICH). 10) 21) Although WAICH is predictive of larger hematoma volume and high rates of hematoma expansion and worse clinical outcome than primary ICH, the mechanisms of these results were not completely understood.
5)11)
Many diseases may lead to ICH; two prominent causes of primary ICH are cerebral amyloid angiopathy in lobar ICH and deep perforating artery vasculopathy in deep ICH.
2) 20) This was indicated with autopsy in prognosis of an ICH (PITCH) cohort. 7) The
Radiological analysis
We checked computed tomography (CT) scans at admission and after 4 hours in all ICH patients, with continuous slices, no gap, and 5 mm slice thickness.
We distributed the location of ICH: (1) lobar (frontal, temporal, parietal, and occipital) when the origin of hemorrhage appeared to be in the cerebral hemisphere superficial to the deep gray matter structure;
(2) deep when originating from basal ganglia and thalamus (3) in the posterior fossa when originating from the brain stem or cerebellum and (4) undetermined in case of ICH when the origin could not be identified and including huge ICH cases that overlapped two categories. We calculated the volume of ICH according to the ABC/2 method. 19) The expansion of hematoma was defined as increasing by 33% and 6 cc in hematoma volume over 4 hours.
Statistical analyses
To ascertain factors associated with warfarin, we used х2-test and independent samples t-test for com- 
RESULTS

Study population and prevalence of warfarin
Effects of warfarin on ICH volume
Taking warfarin showed significant association with a larger volume of ICH compared with the other group (p < 0.001) (Fig. 2) . In multiple linear regression on all documented patients, the only predictor of larger hematoma was the location of ICH (p = 0.001).
After sorting our cohorts according to the location of ICH, we performed multiple linear regression analysis ( (Fig. 3) .
Effect of warfarin on hematoma expansion
In our cohorts, more than 33% of hematoma volume was increased in 144 cases and hematoma volume of 6 cc or more was increased in 92 cases. In our cohorts, 44 cases showed a hematoma increase of both percentage and volume.
Taking warfarin showed significant association with the expansion of ICH (p < 0.001). In our cohorts, the only predictor of expansion was the lobar location of ICH (p = 0.037, OR 2.08, 95% CI:1.05-4.14). After dividing patients according to the location of ICH, we performed multiple linear regression analysis (Table   4 ): (1) in lobar ICH, patients under warfarin showed more hematoma expansion (p = 0.001); and (2) in non-lobar ICH patients, taking warfarin also influenced the expansion of ICH (p < 0.001) (Fig. 4 ).
To elucidate a dose-response relationship between INR value and the ratio of expansion in ICH, we performed an analysis with INR categories. We found that higher INR value was not associated with the ex- After dividing the location of ICH, expansion of hematoma was not affected by INR value (Fig. 5) .
Probability of WAICH and lobar hemorrhage
Results of multivariate logistic regression analysis of the risk factors in WAICH are shown in Table 5 .
History of AF and ischemic stroke showed strong as- In patients taking warfarin, we found that the hematoma volume differed depending on the location of ICH. In our study, the lobar location was the most important factor affecting the volume of ICH and the and dependency in ICH. 6) Every 1 ml of hematoma expansion was estimated to be associated with a 5% increase in odds of death and dependency. 6) In our study, the intensity of warfarin was not associated with the expansion of ICH. We also found that the location of ICH was the most important factor in hematoma expansion. After dividing patients according to the location of ICH, warfarin was a strong risk factor for hematoma expansion. These results supported that the lobar ICH in patients taking warfarin was ex- pected to have a greater possibility of hematoma expansion.
Results of studies on the location of WAICH have been controversial. Some reports showed a higher proportion of lobar and thalamic hemorrhage in patients taking warfarin. 16)24) On the other hand, another study found that taking warfarin was highly associated with the location of cerebellum, particularly in patients with an INR > 2.5. 26) In our study, the lobar location of ICH was a significant factor of WAICH and the most important risk factor of lobar hemorrhage was also taking warfarin.
Our study has many limitations. This study had a retrospective design, including the small numbers of WAICH. Time from neurologic symptom onset to initial CT scan may affect the volumes of ICH, however, we did not consider this in our cohort study. In addition, our report used the ABC/2 method for calculation of hematoma volume. This method has been re- 
CONCLUSION
In our study, taking warfarin showed a signification association with the occurrence, volume of hematoma, and expansion of lobar ICH. In addition, the intensity of anticoagulation is associated with larger hematoma volume in lobar ICH. In patients suspected as having high risk factor for lobar ICH, such as amyloid angiopathy, attention should be paid to those taking warfarin.
